Key facts
- This page summarizes Nusrath Sultana's Form 4 filing for SURMODICS INC (SRDX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2022, 15:41.
Nusrath Sultana - 12 Feb 2022 Form 4 Insider Report for SURMODICS INC (SRDX)
- Reporting relationship
- VP, Clinical Affairs
- Issuer ticker
- SRDX
- Reported as of
- 12 Feb 2022
- Net transaction value
- -$31,753
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2022, 15:41:06 UTC
- Prior SEC filing
- 02 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Manders on behalf of Nusrath Sultana
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nusrath Sultana filed Form 4 for SURMODICS INC (SRDX) on 14 Feb 2022.
Change
- Previous filing in this sequence was filed on 02 Dec 2021.
- Current net transaction value: -$31,753.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRDX
transaction
Common Stock
Tax liability
- Transaction value
- $31,753
- Shares
- -762
- Change %
- -10%
- Price
- $41.67
- Shares after
- 6,530
- Date
- 12 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.